Ovid Therapeutics Inc. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Expense Ratios
Working Capital Analysis
52-Week Range
Trailing Returns
ROIC vs WACC
EPS (Diluted)
—
Book Value Per Share
—
Free Cash Flow Per Share
—
Cash Per Share
—
Revenue Per Share
—
OCF Per Share
—
Return on Equity
-17.5%
Return on Assets
-14.3%
Return on Invested Capital
-33.7%
Current Ratio
8.97
Quick Ratio
8.97
Asset Turnover
0.06
R&D / Revenue
352.8%
SBC / Revenue
66.3%
Capex / Revenue
0.0%
Working Capital
$66M
Net Current Asset Value
$54M
Invested Capital
$131M
OCF / Net Income
2.20
FCF / Net Income
2.20
Accruals Ratio (Sloan)
13.9%
Net Debt
$-13M
Net Debt / EBITDA
0.31
Capex Coverage
-788.11
Tangible Common Equity
$131M
TCE / Total Assets
86.6%
NOPAT
$-34M
Cash ROIC
-38.5%
WC / Revenue
911.2%
Capex / D&A
0.00
Reinvestment Rate
0.6%
Asset Growth vs Revenue Growth
-1117.5%
Revenue 5Y CAGR
-10.5%
Book Value 5Y CAGR
24.5%
Stock Price (FY-end)
$2
Market Cap
—
P/E Ratio
—
P/S Ratio
—
P/B Ratio
—
P/TB Ratio
—
P/OCF Ratio
—
P/FCF Ratio
—
Enterprise Value
—
EV / EBITDA
—
EV / Sales
—
EV / FCF
—
FCF Yield
—
Shareholder Yield
—
R&D Yield
—
Capex Yield
—
Graham Number
—
Shares Variation (YoY)
—
Beta (5Y)
0.94
Cost of Equity
9.2%
52W High
$2
52W Low
$0
Trailing Return 1Y
68.0%
Trailing Return 5Y
-39.4%
F-Score (Piotroski)
3.00
Z-Score (Altman)
—
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.